Patents
Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
11/2007
11/21/2007EP1856065A1 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/13/2007CA2248304C Surface modified carbonate materials
11/01/2007WO2007103694A3 Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/01/2007WO2006092507A8 1,2,4-triazine derivatives, preparation and use thereof in human therapy
10/2007
10/31/2007EP1848707A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia
10/31/2007EP1848699A1 Anthranilic acid derivatives as hm74a receptor agonists
10/30/2007US7288567 Inhibitors of histone deacetylase
10/25/2007US20070249838 Deprotonation of pyridine, 2-fluoropyridine, or methoxypyridine with (trimethylsilylmethyl)lithium or neopentyllithium; industrial scale; direct deprotonation and minimized nucleophilic attack on an azaaromatic compound results in improved yields and simplified purification schemes for the deprotonation
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/24/2007EP1846392A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
10/24/2007EP1112743B1 Nitrogenous heterocyclic carboxamide derivatives or salt thereof as antiviral agents
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007056023A3 Thiazole inhibitors targeting resistant kinase mutations
10/18/2007WO2007027493A3 Stabilization of organogels and hydrogels by azide-alkyne[2+3] cycloaddition
10/18/2007US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors
10/18/2007US20070244119 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/17/2007CN101054367A 3-Amino-1,2,4-phentriazine-1,4-dinitrogen oxide dihydrate, its preparation method and application in tumour radiotherapy and chemotherapy
10/17/2007CN100343239C IL-5 inhibiting azauracil pyrimidine derivatives
10/10/2007CN101050202A Compound in triazine class for anti activity of coccidian, preparation method and application
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279444 for controlling undesirable plants
09/2007
09/26/2007EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/26/2007CN101044125A Heterocyclic compounds and methods of use
09/20/2007WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof
09/19/2007EP1833803A2 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
09/18/2007US7271167 Compounds, compositions, and methods
09/12/2007CN101035773A HIV inhibiting 1.2.4-triazin-6-one derivates
09/06/2007US20070208019 Vasculostatic agents and methods of use thereof
08/2007
08/30/2007US20070203207 Heteroaromatic glucokinase activators
08/23/2007US20070197534 3-ethyl-6-[3-(4-morpholinyl)propoxy]-1,2,4-benzotriazine 1,4-dioxide; for treating cancer; radiosensitising in a subject tumor cells of solid tumors in hypoxic conditions
08/22/2007EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof
08/16/2007US20070191372 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
08/09/2007WO2006119400A3 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides
08/01/2007EP1265810B8 Hydrogen getter composition
07/2007
07/25/2007EP1809615A2 Lamotrigine analogs
07/25/2007EP1809614A2 Benzotriazine inhibitors of kinases
07/25/2007CN101005843A Pyrrolotriazine kinase inhibitors
07/19/2007WO2007064931A3 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
07/17/2007CA2283018C Package for safe storage of electrophilic fluorinating agent
07/12/2007US20070161726 Highly compatible hydroxyphenyltriazine UV-absorbers
07/11/2007EP1805515A2 Immunoassays for lamotrigine
07/11/2007CN1995025A Preparation and uses of triaza benzophenone cluster compound
07/11/2007CN1325480C Novel phenylalanine derivatives
07/05/2007WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof
07/05/2007US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
06/2007
06/27/2007EP1799656A1 Heterocyclic compounds and methods of use
06/27/2007EP1140873B1 Il-5 inhibiting 6-azauracil derivatives
06/26/2007US7235657 Methods for preparing P2X7 inhibitors
06/26/2007US7235549 Benzamide, heteroarylamide and reverse amides
06/21/2007WO2007069265A1 A novel process for the synthesis of lamotrigine and its intermediate
06/20/2007EP1797050A1 Hiv inhibiting 1.2.4-triazin-6-one derivates
06/14/2007US20070135438 Inhibitors of histone deacetylase for the treatment of disease
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007CN1980902A Method for preparing 5-'4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h'1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
06/13/2007CN1978436A Polypeptide synthetic condensation agent 3-hydroxy-4-oxy-3,4-dihydro-1,2,3-benzotriazozine synthesizing method
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230003 Aromatic prodrugs of propofol, compositions and uses thereof
06/07/2007WO2007063934A1 Alicyclic heterocyclic compound
06/07/2007CA2631741A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/06/2007CN1976908A Method for preparing 5-[4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]-triazin-2-yl]benzamide derivatives with P 2 X 7 inhibiting activity by reaction of the derivative unsubstituted in 4-positi
05/2007
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/29/2007US7223868 Heteroaromatic glucokinase activators
05/22/2007CA2368347C Glucokinase activators
05/18/2007WO2007027719A3 Lisofylline analogues and their pharmeacuetical uses
05/10/2007WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
05/09/2007CN1314393C Method for treating hair-dropping using thyromimetic compound
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
04/2007
04/25/2007EP1776352A1 Method for preparing 5-[4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h[1,2,4]triazin-2-yl]-benzamide derivatives by deprotecting the hydroxyl-protected precursers
04/25/2007CN1954446A 有机电致发光元件 Organic electroluminescent element
04/24/2007US7208493 Vasculostatic agents and methods of use thereof
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/12/2007WO2007039463A1 Nnrt inhibitors
04/12/2007US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma
04/12/2007CA2623728A1 Nnrt inhibitors
04/10/2007US7202244 Chk-1 inhibitors
04/04/2007EP1768965A1 Method for preparing 5-¬4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-¬1,2,4|-triazin-2-yl|benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid
04/03/2007CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
03/2007
03/20/2007US7192959 Sodium channel blockers
03/14/2007EP1761268A2 Pyrrolotriazine kinase inhibitors
03/14/2007CN1304371C Heterocyclically substituted benzoylureas, their pharmaceuticals and use of preparing pharmaceuticals
03/13/2007US7189719 Sodium channel blockers
03/13/2007CA2216064C Selective herbicides based on metribuzin and substituted imidazo[1,2-a]pyridin-3-yl-sulfonyl compounds
03/08/2007WO2004026846A8 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
03/08/2007US20070051944 Organic electroluminescent element
03/08/2007CA2618970A1 Lisofylline analogs and methods for use
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/06/2007US7186834 Substituted iminoazines
03/06/2007CA2366521C A new and efficient process for the preparation of lamotrigine and related 3,5-diamino-6-substituted-1,2,4-triazines
02/2007
02/28/2007CN1301973C Heterocyclic derivatives and medicines
02/22/2007US20070043220 {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid; diabetes mellitus, Metabolic Syndrome, atherosclerosis, cardiovascular diseases,Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension
02/22/2007US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease
02/21/2007EP1753747A1 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents
02/20/2007US7179913 Process for preparing a pharmaceutically active compound and for preparing its intermediate
02/20/2007US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents
02/15/2007WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases
02/15/2007US20070037811 Hiv inhibiting 1,2,4-triazines
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/14/2007EP1751122A1 Monomer 5,6-diphenyl-1,2,4-triazinic derivatives and the use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 30